ArticleBMC pediatrics2022

The efficacy of pegylated interferon alpha-2a and entecavir in HBeAg-positive children and adolescents with chronic hepatitis B.

Yi He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.